Market Place
Sourcing Support
Seismic Presents S-1117 Data for Immune Thrombocytopenia at ASH
09 Dec 2024 //
BUSINESSWIRE
Seismic Presents Preclinical Data on S-4321 for Autoimmune Diseases
18 Nov 2024 //
BUSINESSWIRE
Seismic Therapeutic to Participate in Upcoming Investor Conferences
07 Nov 2024 //
BUSINESSWIRE
Seismic Therapeutic Presents Data on IMPACT Platform for Biologics
06 Nov 2024 //
BUSINESSWIRE
Seismic Therapeutics to Present at Upcoming Scientific Conferences
05 Nov 2024 //
BUSINESSWIRE
Seismic Presents Data On S-1117 In Autoantibody Diseases
15 Oct 2024 //
BUSINESSWIRE
Seismic Therapeutic to participate In Upcoming Conferences
30 Sep 2024 //
BUSINESSWIRE
Seismic Therapeutic Appoints Julie Eastland To Board
23 Sep 2024 //
BUSINESSWIRE
Seismic Therapeutic to Participate in Upcoming Investor Conferences
26 Aug 2024 //
BUSINESSWIRE
Seismic Therapeutic Appoints Brendan St. Amant as General Counsel
25 Jun 2024 //
BUSINESSWIRE
Seismic Therapeutic: Presenting At June 2024 Conferences
04 Jun 2024 //
BUSINESSWIRE
Seismic Therapeutic to Participate in Upcoming June Investor Conferences
29 May 2024 //
BUSINESSWIRE
Seismic: S-1117 Autoimmune Preclinical Data At AAN 2024
12 Apr 2024 //
BUSINESSWIRE
Seismic to Present Preclinical Data for Novel Immunoglobulin Sculpting Enzyme
08 Mar 2024 //
BUSINESSWIRE
Seismic Therapeutic Closes $121 Million Series B Financing
04 Dec 2023 //
BUSINESSWIRE
Seismic shakes up $121M for preclinical immunology programs
04 Dec 2023 //
FIERCE BIOTECH
Seismic Announces Presentation of Data for Advancing Biologics Drug Programs
14 Jun 2023 //
BUSINESSWIRE
Seismic Announces Presentation of Data Showing Advances in Biologics Discovery
11 May 2023 //
BUSINESSWIRE
Seismic Announces Preclinical Data for Immunoglobin Sculpting Enzyme
09 May 2023 //
BUSINESSWIRE
Seismic Therapeutic Appoints Melanie Manning as Chief People Officer
27 Mar 2023 //
BUSINESSWIRE
Seismic Therapeutic Appoints Maude Tessier, PhD, as Chief Business Officer
03 May 2022 //
BUSINESSWIRE
Seismic Appoints Eric Larson as Senior VP, Finance and Heather Vital as VP, R&D
13 Apr 2022 //
BUSINESSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.